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Recent studies on Xenopus development have revealed an increasingly complex array of inductive, prepatterning, and
competence signals that are necessary for proper mesoderm formation. In this study, we establish that ®broblast growth
factor (FGF) signals through mitogen-activated protein kinase kinase (MAPKK) to induce mesodermal gene expression. We
demonstrate that a partially activated form of MAPKK restores expression of the mesodermal genes Xcad-3 and Xbra,
eliminated by the dominant-negative FGF receptor (DFGFR). Similar to the results reported earlier withDFGFR, expression
of a dominant-negative form of MAPKK (MAPKKD) preferentially eliminates the dorsal expression of Xcad-3 and Xbra.
We tested whether the regional localization of bone morphogenetic protein-4 (BMP-4) could explain why both MAPKKD
and DFGFR eliminate the dorsal and not the ventral expression of Xcad-3 and Xbra. We show that ectopic expression of
BMP-4 is suf®cient to maintain the dorsal expression of Xcad-3 and Xbra in embryos containingDFGFR and that expression
of a dominant-negative BMP receptor reduces the dorsal±ventral differences in DFGFR embryos. These results indicate
that regional localization of BMP-4 is responsible for the dorsal±ventral asymmetry in FGF/MAPKK-mediated mesoderm
induction. q 1995 Academic Press, Inc.
INTRODUCTION Our goal has been to establish the signaling pathways
that lead to the formation of mesoderm in vivo. Previous
A central focus of vertebrate developmental biologists studies have indicated that the FGF receptor (Amaya et al.,
over the past several decades has been to identify the inter- 1991), a SH2-containing protein tyrosine phosphatase (SH-
cellular signals that are responsible for inducing and pat- PTP2; Tang et al., 1995), Ras (Whitman and Melton, 1992),
terning the mesoderm. In recent years, several candidate and Raf (MacNicol et al., 1993) are necessary for FGF-medi-
mesoderm-inducing factors have been identi®ed, including ated mesoderm induction. Since addition of FGF to embry-
members of the ®broblast growth factor (FGF) family and onic explants causes an increase in mitogen-activated pro-
members of the transforming growth factor-b (TGF-b) fam- tein kinase (MAPK) activation, it is likely that FGF-medi-
ily (reviewed in Kimelman et al., 1992; Sive, 1993; Kessler ated activation of Raf leads to an elevation in MAPK
and Melton, 1994). Other intercellular signaling molecules activity by activating MAPK kinase (MAPKK); (Graves et
have been identi®ed that pattern the mesoderm by altering al., 1994; Hartley et al., 1994; LaBonne and Whitman, 1994).
the competence of the cells that respond to mesoderm-in- However, Raf has been shown to have intracellular targets
ducing agents. These include members of the Wnt family other than MAPKK (Li and Sedivy, 1993; Radziwill et al.,
(reviewed in Moon et al., 1993), noggin (Smith and Harland, 1995). In addition, other intracellular proteins activated by
1992), and chordin (Sasai et al., 1994). FGF, such as phospholipase Cg and PKC, have been shown
not to be necessary for mesoderm formation (Gillespie et
al., 1992; Muslin et al., 1994; Ryan and Gillespie, 1994). It1 To whom correspondence should be addressed at Department of
is therefore not clear whether activation of MAPK is neces-Biochemistry, Box 357350, University of Washington, Seattle, WA
98195-7350. Fax: (206) 685-1792. email: kimelman @u.washington.edu. sary for mesoderm induction.
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We show here that MAPKK is an important component RNA Synthesis and Microinjection
of mesodermal induction in Xenopus embryos. Ectopic ex- RNAs encoding MAPKK*, MAPKKD, MAPKKwt,
pression of an activated form of MAPKK expands the expres-
DFGFR (Amaya et al., 1991), DXBMPR (A.S. and N.U., un-
sion domains of two pan-mesodermal markers, Xcad-3 and published data), and BMP-4 (Dale et al., 1992) were synthe-
Xbra, and it overcomes the inhibition of dorsal Xcad-3 and sized in vitro. MAPKK*, MAPKKD, and MAPKKwt were
Xbra expression caused by a dominant-negative FGF recep- linearized with BamHI, DFGFR and DXBMPR were linear-
tor (DFGFR). Complementary studies by Gotoh et al. (1995) ized with EcoRI, and BMP-4 was linearized with SalI. RNA
and LaBonne et al. (1995) demonstrate that an activated was synthesized using the SP6 mMessage mMachine kit
form of MAPKK is able to induce mesoderm in animal cap (Ambion) following the manufacturer's instructions with
explants. In addition, we show that expression of a domi- the exception that after DNAse I treatment, the RNA was
nant-negative form of MAPKK selectively inhibits the ex- extracted with phenol:chloroform (1:1) and unincorporated
pression of Xbra and Xcad-3 in the dorsal region of the nucleotides were extracted with a microcon 100 micro-
Xenopus gastrula stage embryo. These results demonstrate concentrator (Amicon). Yields were quantitated by UV spec-
that the MAPK pathway is necessary and suf®cient for the trophotometry. RNA was diluted to the appropriate concen-
FGF-mediated induction of mesoderm. Furthermore, we trations and injected as 10-nl volumes. When mixtures of
show that the asymmetry in the response to inhibition of RNAs were used, the components were mixed such that a
the FGF/MAPKK pathway can be explained by the regional single injection of 10 nl would be necessary at each injection
localization of bone morphogenetic protein-4 (BMP-4), a site. Embryos at the 2- to 4-cell stage were injected on both
member of the TGF-b family. We demonstrate that ectopic sides of the ®rst cleavage furrow in the marginal zone on
expression of BMP-4 can rescue Xcad-3 and Xbra expression both the dorsal and the ventral sides of the embryo (a total of
in the dorsal region of embryos injected with RNA encoding four injections per embryo) following published procedures
DFGFR. In addition, coexpression of DFGFR and a domi- (Moon and Christian, 1989).
nant-negative BMP receptor eliminates expression of Xcad-
3 and Xbra in both the dorsal and ventral regions of the
embryo. These results demonstrate that even the relatively In Situ Hybridization and Probe Synthesis
simple expression patterns of the pan-mesodermal markers Whole-mount in situ hybridization was performed using
Xcad-3 and Xbra can be regulated by combinations of sig- digoxigenin-labeled RNA probes (Harland, 1991), with sev-
naling factors and that the combination of factors responsi- eral modi®cations according to Anne Knecht and Richard
ble for expression of a gene may vary from region to region Harland (personal communication). In addition, the follow-
for an individual gene. ing steps were also modi®ed: probes were not digested with
sodium carbonate, the RNase digestion step was omitted,
and levamisole was eliminated from the alkaline phosphate
buffer. These modi®cations produced the same staining pat-MATERIALS AND METHODS
terns as the original protocol; however, the stain appeared
more rapidly and was more intense with little increase inEmbryos
background staining. The Xcad-3 probe was synthesized
Fertilized eggs were obtained as previously described from a EcoRV-digested pXcad-50 construct using T3 as pre-
(Newport and Kirschner, 1982). Eggs were fertilized in 0.51 viously described (Northrop and Kimelman, 1994). The
MMR (11MMR is 0.1 M NaCl, 2 mM KCl, 1.0 mM MgSO4, Xbra antisense probe was synthesized from an EcoRV digest
2.0 mM CaCl2, 5.0 mM Hepes, and 0.1 mM EDTA, pH 7.8). and transcribed with T7 (Smith et al., 1991).
The jelly coat was removed 20 min postfertilization with
2% cysteine, pH 7.8, washed a minimum of three times in
0.11MMR, and then incubated in 0.11MMR at 14 to 237C. RESULTS
Embryos were staged following the methods of Nieuwkoop
and Faber (1967). Construction of MAPKK* and MAPKKD
Expression Vectors
Important regulatory regions and sites of phosphorylationConstruction of Transcription Vectors Containing
have been identi®ed in several protein kinases and deletionMAPKK and MAPKK Mutants
or mutation of these sites frequently results in proteins with
altered biological activity. MAPKK has previously beenConstruction of MKK1a and of the partially-activated
(S222E) and dominant-negative (S222A) mutations have shown to be regulated by serine phosphorylation (Gomez
and Cohen, 1991; Kyriakis et al., 1992) and in vitro studiesbeen described previously (Seger et al., 1992, 1994). The
fragments encoding MAPKK and the corresponding muta- of MAPKK activity have suggested an essential role for ser-
ine 222 phosphorylation in activating Xenopus MAPKKtions were excised from the original pcDNA3 vector (In-
vitrogen), BamHI linkers were added, and the fragments (Gotoh et al., 1994). Therefore, serine 222 of the human
MAPKK (MKK1a; Seger et al., 1992) was mutated to alaninewere inserted into the BglII site of SP64T (Krieg and Melton,
1984). (S222A) in an attempt to create a dominant-negative
Copyright q 1995 by Academic Press, Inc. All rights of reproduction in any form reserved.
/ m3814$8002 10-18-95 10:43:58 dbal Dev Bio
244 Northrop et al.
ing mutation and was not due to the overexpression of
MAPKK. These results show that MAPKK* is able to induce
expression of the mesodermal markers Xcad-3 and Xbra
beyond their normal boundaries of expression in the ventral
region of the embryo, but it cannot induce signi®cant ex-
pression of these genes in the animal cap region or on the
dorsal side of the embryo.
FIG. 1. Site of MAPKK mutations. Illustrated is a schematic repre- MAPKK* Can Rescue Expression of Xcad-3 andsentation of MAPKK indicating the site of the serine residue at
Xbra in Embryos Co-Injected with DFGFRposition 222 which has been mutated to glutamic acid for MAPKK*
and to alanine for MAPKKD. We examined whether MAPKK* could rescue FGF signal-
ing during mesoderm induction in embryos expressing
DFGFR. Embryos were injected at the 2- to 4-cell stage in
the dorsal and ventral marginal zone with RNA encoding
MAPKK and to glutamic acid (S222E) in an attempt to con- MAPKK*, DFGFR, or a mixture of MAPKK* and DFGFR.
stitutively activate the enzyme (Fig. 1; Seger et al., 1994). Embryos treated with DFGFR exhibited reduced expression
These constructs were found to be dominant-negative and of Xcad-3 and Xbra in the dorsal marginal region of the
partially activated when expressed in NIH 3T3 cells (Seger embryos as previously described (Northrop and Kimelman,
et al., 1994). MKK1a and the two mutations S222A and 1994; Figs. 3C and 3C* and Table 1). When MAPKK* was
S222E were then inserted into the Xenopus RNA expression co-injected with DFGFR, dorsal expression of both Xcad-3
vector, SP64T (Krieg and Melton, 1984), and are referred and Xbra was rescued (Figs. 3D and 3D* and Table 1).
to as MAPKKwt, MAPKKD, and MAPKK*, respectively. MAPKK* was more ef®cient at rescuing the DFGFR-medi-
RNAs encoding these proteins were transcribed in vitro and ated inhibition of Xbra than is apparent in Table 1. Al-
injected into Xenopus embryos at the 2- to 4-cell stage in though co-injection of MAPKK* did not always restore com-
order to study the role of MAPKK in Xenopus mesoderm plete Xbra expression, embryos injected with MAPKK* and
induction. DFGFR consistently had a smaller region lacking Xbra ex-
pression than was observed in embryos injected with
DFGFR alone, demonstrating that some degree of rescueInjection of RNA Encoding MAPKK* Expands the
occurred.Ventral Expression of Xcad-3 and Xbra
Embryos were also injected with RNA encoding
MAPKKwt or a mixture of MAPKKwt and DFGFR to deter-In order to determine whether MAPKK* is suf®cient to
ectopically induce expression of mesodermal genes, RNA mine whether the effects we observed were speci®cally due
to the expression of an activated form of MAPKK or wereencoding MAPKK* was injected either into the animal pole
region of each blastomere of 4-cell stage Xenopus embryos due to an increase in the levels of MAPKK expression. Injec-
tion of RNA encoding MAPKKwt was unable to rescue ex-or into the dorsal and ventral marginal zones on both sides
of the ®rst cleavage plane of 2- to 4-cell stage embryos. pression of Xcad-3 and Xbra in embryos co-injected with
DFGFR (Table 1). Furthermore, we did not observe any par-Expression of the pan-mesodermal markers, Xcad-3 and
Xbra, was then examined by in situ hybridization. Xcad-3 tial rescue of Xbra expression in DFGFR embryos co-in-
jected with MAPKKwt as discussed above for embryos co-and Xbra are normally expressed in a band of cells encircling
the blastopore lip in gastrula stage embryos (Smith et al., injected with MAPKK*. These experiments demonstrate
that the introduction of an activated form of MAPKK is1991; Northrop and Kimelman, 1994; Fig. 2A and 2A*). The
expression patterns of these two genes are very similar at able to speci®cally overcome the inhibition of expression
of Xcad-3 and Xbra caused by DFGFR.the early to mid-gastrula stages except that Xcad-3 expres-
sion is somewhat fainter in the dorsal region, but this varies
among batches of embryos (compare Figs. 3A and 6A). In
Injection of RNA Encoding MAPKKD Disrupts theapproximately 80% of the embryos injected in either the
Dorsal Expression of Xcad-3 and Xbraanimal pole region or in the dorsal and ventral marginal
zone, the expression of both Xcad-3 and Xbra expanded Since an activated MAPKK can rescue a block in the FGF
signal transduction pathway, we next examined whether abeyond the normal marginal zone expression pattern in the
ventral, but not the dorsal, region of the embryo (Figs. 2B dominant-negative construct of MAPKK could cause the
same effects on mesodermal gene expression as the domi-and 2B*). While expansion of ventral expression of Xcad-3
and Xbra were observed at the same frequency, the ventral nant-negative FGF receptor. RNA encoding MAPKKD was
injected into the dorsal and ventral marginal zone of em-expansion of Xcad-3 usually covered a larger area than the
ventral expansion of Xbra expression (data not shown). Em- bryos at the 2- to 4-cell stage on both sides of the ®rst
cleavage plane. MAPKKD inhibited expression of Xcad-3bryos that were injected with RNA encoding MAPKKwt did
not exhibit any expansion of Xcad-3 or Xbra expression and Xbra preferentially in the dorsal region of the embryo
(Figs. 4C and 4C*). In a total of 18 independent experiments,(data not shown). Therefore, this effect required the activat-
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Xcad-3 expression was eliminated from the dorsal region of increased resistance of Xcad-3 and Xbra ventral expression
to the effects of DFGFR. It has recently been determinedgastrula stage embryos in 49% of the samples (157/320)
while ventral reduction of expression was never observed that BMP-4 transcripts are localized to the ventral and lat-
eral regions of the gastrula stage embryo, but are absent(data not shown). In embryos stained for Xbra expression,
dorsal staining was eliminated in 63% of the embryos (198/ from the dorsal side (Fainsod et al., 1994; Schmidt et al.,
1995), making BMP-4 an excellent candidate for a regionally313) while ventral reduction of expression was seen in only
3.5% of the embryos (11/313; data not shown). These results localized molecule affecting FGF/MAPKK signaling.
are similar to the effect seen in embryos expressingDFGFR In order to determine whether BMP-4 is responsible for
(Northrop and Kimelman, 1994). the dorsal±ventral differences observed for FGF- and
To demonstrate that the elimination of gene expression MAPKK-mediated signaling, we decided to use RNA encod-
was a speci®c effect of MAPKKD, RNAs encoding MAPKK* ing DFGFR rather than MAPKKD. We have demonstrated
and MAPKKD were co-injected in the dorsal and ventral above that MAPKK is part of the mesoderm-inducing signal
marginal zone of 2- to 4-cell stage embryos. MAPKK* was transduction cascade activated by FGF and that blocking
able to effectively rescue the dorsal reduction of Xcad-3 and the pathway at either step produces the same results on
Xbra expression in embryos expressing MAPKKD (Figs. 4D Xcad-3 and Xbra expression. Since MAPKKD required a 5-
and 4D* and Table 2). As a further control, RNA encoding to 10-fold higher dose of RNA than DFGFR to eliminate
MAPKKwt was injected both alone and in combination Xcad-3 and Xbra expression from the dorsal region of the
with MAPKKD. MAPKKwt did not reduce expression of embryo, it was easier to inject combinations of RNA using
Xcad-3 and Xbra when injected alone, and when co-injected DFGFR.
with MAPKKD, it was unable to rescue mesodermal gene To characterize the effects of BMP-4 in the presence of
expression (data not shown). These results demonstrate that DFGFR, RNA encoding BMP-4,DFGFR, or a mixture of the
the elimination of dorsal expression of Xcad-3 and Xbra is two was injected into the dorsal and ventral marginal zone
due to a speci®c effect of MAPKKD and that MAPKKD can of a 2- to 4-cell stage embryo. The embryos were then scored
produce the same types of changes in gene expression as during the mid-gastrula stages for expression of Xcad-3 and
was observed with DFGFR. Xbra. Injection of BMP-4 alone expanded the marginal zone
expression of both genes in both the dorsal and the ventral
regions of the embryo and occasionally expanded the expres-
BMP-4 Rescues the Dorsal Expression of Xcad-3 sion throughout the entire animal hemisphere (Schmidt et
and Xbra in DFGFR-Injected Embryos al., 1995; data not shown). Injection of DFGFR eliminated
dorsal expression of Xcad-3 and Xbra in 96% of each ofOur previous study (Northrop and Kimelman, 1994), and
the samples (Table 3). Co-injection of BMP-4 with DFGFRthe work discussed above, demonstrated that the Xenopus
RNAs effectively rescued expression of both genes but wasembryo has a dorsal±ventral asymmetry in its response to
somewhat more ef®cient at rescuing Xcad-3 than Xbra ex-inhibition of FGF signaling through the MAPKK pathway.
pression (Figs. 5D and 5D* and Table 3). BMP-4 rescued overOne possible explanation for the dorsal±ventral difference
80% of the dorsal Xcad-3 expression in embryos injectedis the regional localization of another factor which affects
with DFGFR, whereas only about 50% of the embryosthe response of Xcad-3 and Xbra to inhibition of the FGF/
stained for Xbra expression were rescued by BMP-4 co-injec-MAPKK pathway. For example, a ventralizing factor such
tion (Table 3). In addition, even when Xbra expression wasas BMP-4 (Koster et al., 1991; Dale et al., 1992; Jones et al.,
1992) could act synergistically with FGF, resulting in an rescued in the dorsal region of the embryo, the rescue was
FIG. 2. Injection of RNA encoding MAPKK* expands the ventral expression patterns of Xcad-3 and Xbra in gastrula stage embryos.
Embryos at the 2- to 4-cell stage were injected in both the dorsal and ventral marginal zones with RNA encoding MAPKK* and stained
for Xcad-3 (A and B) and Xbra (A* and B*) expression at the gastrula stage by in situ hybridization. (A and A*) Uninjected embryos (B and
B*), embryos injected with 5 ng RNA encoding MAPKK*. The embryos are oriented with dorsal toward the top of the page and anterior
toward the left.
FIG. 3. RNA encoding MAPKK* injected in both the dorsal and ventral marginal zones can rescue expression of Xcad-3 and Xbra in
embryos co-injected withDFGFR. Uninjected embryos (A and A*), embryos injected with 5 ng RNA encoding MAPKK* (B and B*), embryos
injected with 1 ng RNA encoding DFGFR (C and C*), and embryos co-injected with 5 ng RNA encoding MAPKK* and 1 ng RNA encoding
DFGFR (D and D*) were ®xed at the gastrula stage and stained for Xcad-3 (A±D) and Xbra (A*±D*) expression by in situ hybridization.
Vegetal view, with the dorsal side oriented toward the top of the page. Note that the ventral expansion in embryos injected with MAPKK*
is dif®cult to see in a vegetal view and is frequently less pronounced in embryos stained for Xbra than for Xcad-3 (see text).
FIG. 4. Injection in both the dorsal and ventral marginal zones with RNA encoding MAPKKD disrupts expression of Xcad-3 and Xbra
in a dorsal±ventral-dependent manner, an effect which is blocked by coexpression of MAPKK*. Uninjected embryos (A and A*), embryos
injected with 2 ng RNA encoding MAPKK* (B and B*), embryos injected with 5 ng RNA encoding MAPKKD (C and C*), and embryos co-
injected with 2 ng RNA encoding MAPKK* and 5 ng RNA encoding MAPKKD (D, D*) were ®xed at the gastrula stage and stained for
Xcad-3 (A±D) and Xbra (A*±D*) expression by in situ hybridization. Vegetal view, with the dorsal side oriented toward the top of the
page.
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FIG. 5. BMP-4 rescues the dorsal expression of Xcad-3 and Xbra eliminated in DFGFR-injected embryos when both are co-injected into
the dorsal and ventral marginal zones. Uninjected embryos (A and A*), embryos injected with 1 ng RNA encoding BMP-4 (B and B*),
embryos injected with 1 ng RNA encoding DFGFR (C and C*), and embryos co-injected with 1 ng RNA encoding BMP-4 and 1 ng RNA
encoding DFGFR (D and D*) were ®xed at the gastrula stage and stained for Xcad-3 (A±D) and Xbra (A*±D*) expression by in situ
hybridization. Vegetal view, with the dorsal side oriented toward the top of the page. Note that BMP-4 caused an expansion of Xcad-3
and Xbra expression in the dorsal and ventral animal hemispheres in these embryos which are not observed in this orientation
(B and B*).
FIG. 6. RNA encoding DXBMPR injected in both the dorsal and ventral marginal zones eliminates the dorsal±ventral gradient of
sensitivity to DFGFR. Uninjected embryos (A and A*), embryos injected with 1 ng RNA encoding DXBMPR (B and B*), embryos injected
with 1 ng RNA encodingDFGFR (C and C*), and embryos co-injected with 1 ng RNA encoding DXBMPR and 1 ng RNA encodingDFGFR
(D and D*) were ®xed at the gastrula stage and stained for Xcad-3 (A±D) and Xbra (A*±D*) expression by in situ hybridization. Vegetal
view, with the dorsal side oriented toward the top of the page.
/ m3814$8002 10-18-95 10:43:58 dbal Dev Bio
248 Northrop et al.
TABLE 1
MAPKK* Rescues Xcad-3 and Xbra Expression in Embryos Expressing the Truncated FGF Receptor
Xcad-3a Xbrab
Complete Missing % Missing Complete Missing % Missing
RNA-injected ring of stain dorsal stain dorsal stain ring of stain dorsal stain dorsal stain
None 22 0 0% 159 0 0%
5 ng MAPKK* 57 0 0% 167 0 0%
1 ng DFGFR 9 33 79% 15 142 90%
1 ng DFGFR / 5 33 3 8% 115 72 39%
ng MAPKK*
MAPKKwt 22 0 0% 36 0 0%
1 ng DFGFR / 1 25 96% 6 51 90%
5ng MAPKKwt
Note. Embryos were injected at the two-cell stage in the dorsal and ventral marginal zone with RNA and then harvested at stage 12
(midgastrula) and stained for Xcad-3 or Xbra expression by in situ hybridization.
a Data compiled from two experiments (one experiment included MAPKKwt as a control).
b Data compiled from seven experiments (two experiments included MAPKKwt as a control).
less ef®cient than the rescue of dorsal Xcad-3 expression results do not demonstrate whether this is a role of endoge-
nous BMP-4. To examine whether disruption of the BMP-(Figs. 5D and 5D*). These results demonstrate that ectopic
4 signal transduction pathway in whole embryos couldexpression of BMP-4 can rescue the dorsal elimination of
eliminate the dorsal±ventral differences in FGF-mediatedXcad-3 and Xbra expression caused by the dominant-nega-
mesoderm induction, a Xenopus dominant-negative BMPtive FGF receptor and suggest that the ventral region of the
receptor (DXBMPR; A.S. and N.U., unpublished results) wasembryo normally requires a lower level of FGF signaling to
co-injected with DFGFR. This truncated BMP receptormaintain Xcad-3 and Xbra expression due to the localiza-
blocks BMP-4 signaling but has little effect on other TGF-tion of BMP-4 transcripts to that region.
b family members such as activin (Schmidt et al., 1995; see
also Graff et al., 1994). If BMP-4 signaling is responsibleRNA Encoding a Dominant-Negative BMP
for maintaining Xbra and Xcad-3 expression in the ventralReceptor Eliminates the Dorsal±Ventral Gradient region of DFGFR-injected embryos, we would expect that
of Sensitivity to DFGFR disruption of the BMP-4 signaling pathway would eliminate
While ectopic expression of BMP-4 can rescue the dorsal± the dorsal±ventral asymmetry. Therefore in embryos in-
jected with both DFGFR and DXBMPR, Xcad-3 and Xbraventral asymmetry when FGF signaling is blocked, these
TABLE 2
MAPKKD Disrupts Dorsal Expression of Xcad-3 and Xbra
Xcad-3a Xbraa
Complete Missing % Missing Complete Missing % Missing
RNA-injected ring of stain dorsal stain dorsal stain ring of stain dorsal stain dorsal stain
No RNA 26 0 0% 42 0 0%
2 ng MAPKK* 50 0 0% 50 0 0%
5 ng MAPKKD 22 17 44% 11 13 54%
2 ng MAPKK* 27 2 7% 30 2 6%
/ 5 ng
MAPKKD
Note. Embryos were injected at the two-cell stage in the dorsal and ventral marginal zone with RNA and then harvested at stage 12
(midgastrula) and stained for Xcad-3 or Xbra expression by in situ hybridization.
a Data compiled from two experiments.
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TABLE 3
BMP4 Rescues Dorsal Expression of Xcad-3 and Xbra in Embryos Expressing DFGFR
Xcad-3a Xbrab
Complete Missing % Missing Complete Missing % Missing
RNA-injected ring of stain dorsal stain dorsal stain ring of stain dorsal stain dorsal stain
No RNA 118 0 0% 126 0 0%
1 ng BMP4 88 0 0% 81 0 0%
1 ng DFGFR 4 85 96% 3 76 96%
1 ng BMP4 / 1 ng 75 10 12% 50 44 47%
DFGFR
Note. Embryos were injected at the two-cell stage in the dorsal and ventral marginal zone with RNA and then harvested at stage 12
(midgastrula) and stained for Xcad-3 or Xbra expression by in situ hybridization.
a Data compiled from ®ve experiments.
b Data compiled from seven experiments.
expression should be inhibited equally on the dorsal and and Xbra expression preferentially from the dorsal region
of the embryo (Figs. 6C and 6C*) and also reduced ventralventral sides of the embryo.
RNA encoding either DXBMPR, DFGFR, or a mixture of Xbra expression in a small subset of the embryos (Table
4). Injection of DXBMPR and DFGFR together resulted inthe two was injected into the dorsal and ventral marginal
zones of Xenopus embryos at the 2-cell stage. Injection of elimination of mesodermal gene expression in both the dor-
sal and the ventral regions of the embryo (Figs. 6D and 6D*).DXBMPR alone rarely altered either Xcad-3 or Xbra expres-
sion during gastrulation (Suzuki et al., 1994; Schmidt et al., Since the RNA injections are speci®cally targeted to the
dorsal and ventral sides, there is often some faint lateral1995; Figs. 6B and 6B*). In 6 out of 131 embryos examined,
there was some minor reduction in dorsal Xcad-3 stain, and expression of Xcad-3 and Xbra remaining in these embryos
(Figs. 6D and 6D*), but expression is frequently completelyin 1 embryo out of 108 examined, there was also a disrup-
tion in Xbra staining (Table 4). It is dif®cult to determine eliminated. None of the embryos injected with DFGFR
RNA alone had reduced ventral Xcad-3 expression, whilewhether there was any signi®cance to this effect since it
was so rarely observed, yet it was not seen in any of the 66% of the embryos injected with both DXBMPR and
DFGFR had Xcad-3 expression eliminated from both thecontrol embryos. Injection of DFGFR eliminated Xcad-3
TABLE 4
DXBMPR Eliminates the Dorsal±Ventral Differences in Xcad-3 and Xbra Expression in Embryos Expressing DFGFR
Xcad-3a Xbrab
Missing Missing
dorsal % Missing dorsal % Missing
Complete Missing and % Missing dorsal and Complete Missing and % Missing dorsal and
ring of dorsal ventral dorsal ventral ring of dorsal ventral dorsal ventral
RNA-injected stain stain stain stain stain stain stain stain stain stain
no RNA 108 0 0 0% 0% 122 0 0 0% 0%
1 ng DXBMPR 125 6 0 5% 0% 107 1 0 1% 0
1 ng DFGFR 33 94 0 74% 0% 3 89 13 85% 12%
1 ng DXBMPR / 1 66 131 33% 66% 4 30 94 23% 73%
1 ng DFGFR
Note. Embryos were injected at the two-cell stage in the dorsal and ventral marginal zone with RNA and then harvested at stage 12
(midgastrula) and stained for Xcad-3 or Xbra expression by in situ hybridization.
a Data compiled from ®ve experiments.
b Data compiled from seven experiments.
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dorsal and the ventral regions (Table 4). In embryos stained tor (¯g) between the dorsal and ventral regions of the Xeno-
pus embryo (Ding et al., 1992; Song and Slack, 1994). Infor Xbra expression, 73% exhibited both a dorsal and ventral
reduction in stain when co-injected with DXBMPR and addition, as shown in this report, MAPKK exhibits a similar
dorsal±ventral asymmetry in its ability to effect Xcad-3 andDFGFR, whereas only 12% lacked Xbra expression in both
regions when injected with RNA encoding DFGFR alone Xbra expression. Finally, MAPK is activated to a similar
extent by FGF in animal cap explants isolated from either(Table 4). These results demonstrate that coexpression of a
dominant-negative BMP receptor reduces the dorsal±ven- the dorsal or the ventral regions of the embryo (L. Graves,
J.N., E.K., and D.K., unpublished results). These results indi-tral asymmetry of FGF-mediated mesoderm induction.
cate that the dorsal±ventral differences observed in FGF-
mediated mesoderm induction are not likely to be due to
asymmetrically distributed components of the FGF signalDISCUSSION
transduction pathway, but rather that the observed dorsal±
ventral differences might be due to the presence of anotherMAPKK Is Responsible for FGF-Mediated
asymmetrically active factor.Induction of Xcad-3 and Xbra Expression
One possibility is that a ventrally localized factor could
In this report we have shown that MAPKK is necessary enhance Xcad-3 and Xbra expression and thereby cause ex-
and suf®cient for FGF-mediated mesoderm induction of pression of these two genes to be more resistant to disrup-
Xcad-3 and Xbra in the Xenopus embryo. We have demon- tions in the FGF/MAPKK signaling pathway in the ventral
strated that ectopic expression of MAPKK* is suf®cient to region of the embryo. Recent studies have shown that BMP-
rescue the elimination of Xcad-3 and Xbra expression 4 transcripts are localized to the lateral and ventral regions
caused by DFGFR. This effect is due to the activating muta- of the gastrula stage embryo but are absent from the dorsal
tion (serine to glutamic acid), since overexpression of region (Fainsod et al., 1994; Schmidt et al., 1995). Therefore,
MAPKKwt did not rescue mesodermal gene expression in BMP-4 is a strong candidate to regionally affect the ability
embryos expressing DFGFR. In complementary studies, ac- of FGF to induce and maintain Xcad-3 and Xbra expression.
tivated forms of MAPKK (Gotoh et al., 1995; LaBonne et Our results indicate that endogenous BMP-4 reduces the
al., 1995) and MAPK (LaBonne et al., 1995) were shown to level of FGF signaling that is necessary for Xcad-3 and Xbra
induce expression of Xbra in animal caps. expression. When FGF signaling is disrupted by expression
We have demonstrated that MAPKK is necessary for of DFGFR, the dorsal mesoderm, which lacks BMP-4 tran-
mesoderm induction by ectopically expressing RNA encod- scripts, is no longer able to maintain Xcad-3 and Xbra ex-
ing MAPKKD and eliminating the dorsal expression of the pression. This inhibitory effect of DFGFR can be overcome
mesodermal genes Xcad-3 and Xbra. The preferential elimi- by ectopic expression of BMP-4. Furthermore, while expres-
nation of dorsal expression of these two mesodermal mark- sion of a dominant-negative BMP receptor alone rarely af-
ers is the same effect observed when RNA encodingDFGFR fected Xcad-3 and Xbra expression patterns, co-injection
is expressed. This elimination of Xcad-3 and Xbra expres- with DFGFR eliminated Xcad-3 and Xbra transcripts from
sion is a speci®c effect of the MAPKKD mutation (serine to both the dorsal and ventral regions of the gastrula stage
alanine) since expression of neither MAPKKwt or MAPKK* Xenopus embryo. These results indicate that the dorsal±
reduced the expression of Xcad-3 and Xbra. In addition, ventral differences in the sensitivity of Xcad-3 and Xbra to
expression of these two mesodermal markers are rescued DFGFR can be explained by the absence of BMP-4 from the
by coexpressingg RNA encoding MAPKK* with MAPKKD dorsal region of the embryo.
RNA, indicating that this effect is due to interference with
MAPKK signaling and not due to nonspeci®c effects of RNA
Differential Regulation of Xbra and Xcad-3 by FGFoverexpression. Further evidence that MAPKK and MAPK
are necessary for mesoderm induction comes from the stud- Although both Xcad-3 and Xbra are preferentially elimi-
ies of Gotoh et al. (1995) and LaBonne et al. (1995). Both nated from the dorsal side of the embryo by DFGFR, Xbra
groups demonstrated that a MAPK-speci®c phosphatase can expression is disrupted at lower doses of DFGFR RNA than
block the FGF-mediated formation of mesoderm in animal is Xcad-3 expression (Northrop and Kimelman, 1994).
cap explants and produce embryos with a similar phenotype These results suggest that the expression of Xbra may re-
to that caused by ectopic expression of DFGFR. quire a higher level of FGF signaling. In accordance with
this hypothesis, we ®nd that both MAPKK* and BMP-4
rescue the elimination of Xcad-3 expression by DFGFRRegional Localization of BMP-4 Contributes to the
more ef®ciently than they rescue Xbra expression (see Ta-Dorsal±Ventral Asymmetry of FGF-Mediated
bles 1 and 3 and compare the dorsal region of Xcad-3 andMesoderm Induction
Xbra expression in Figs. 3D and D* and 5D and 5D*). In
addition, MAPKK* is able to expand the ventral region ofThe dorsal±ventral differences in the response of Xcad-3
and Xbra expression to perturbations in the FGF/MAPKK Xcad-3 expression to a greater extent than it expands ven-
tral Xbra expression. This observed difference in the re-pathway are not likely to be due to asymmetric distribution
of FGF or its receptor since there is no apparent difference quirements for FGF signaling levels for maintaining Xcad-
3 and Xbra expression may be due to an additional factor(s)in the concentration of bFGF or the endogenous FGF recep-
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